Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis

Vuckovic Biljana A.; Djeric Mirjana J.; Tomic Branko V.; Djordjevic Valentina J.; Bajkin Branislav V.; Mitic Gorana P.

首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis

【24h】

Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis

机译：纤维蛋白溶解活性和纤溶酶原激活剂抑制剂-14g / 5g多态性对静脉血栓形成风险的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective of our study is to determine whether decreased fibrinolytic activity or plasminogen activator inhibitor (PAI)-1 4G/5G polymorphism influence the risk of venous thrombosis.

机译：我们研究的目的是确定纤维蛋白溶解活性或纤溶酶原激活活化剂抑制剂（PAI）-1 4G / 5G多态性是否会影响静脉血栓形成的风险。

著录项

来源
《Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis 》 |2018年第1期| 共6页
作者
Vuckovic Biljana A.; Djeric Mirjana J.; Tomic Branko V.; Djordjevic Valentina J.; Bajkin Branislav V.; Mitic Gorana P.;
展开▼
作者单位

Univ Novi Sad Fac Med Ctr Lab Med Novi Sad Serbia;

Univ Novi Sad Fac Med Ctr Lab Med Novi Sad Serbia;

Univ Belgrade Inst Mol Genet &

Genet Engn Vojvode Stepe 444a Belgrade 11010 Serbia;

Univ Belgrade Inst Mol Genet &

Genet Engn Vojvode Stepe 444a Belgrade 11010 Serbia;

Univ Novi Sad Fac Med Novi Sad Dent Clin Vojvodina Novi Sad Serbia;

Univ Novi Sad Fac Med Ctr Lab Med Novi Sad Serbia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生 ;
关键词
fibrinolysis; genetics; plasminogen activator inhibitor-1; risk factors; thrombosis;

机译：纤维蛋白溶解;遗传学;纤溶酶原激活剂抑制剂-1;危险因素;血栓形成;

相似文献

外文文献
中文文献
专利

1. Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis [J] . Vuckovic Biljana A., Djeric Mirjana J., Tomic Branko V., Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2018 ,第1期

机译：纤维蛋白溶解活性和纤溶酶原激活剂抑制剂-14g / 5g多态性对静脉血栓形成风险的影响
2. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study [J] . Prabhudesai Aniket, Shetty Shrimati, Ghosh Kanjaksha, European Journal of Haematology . 2017 ,第3期

机译：印度静脉血栓形成患者纤溶酶原激活剂抑制剂-1（PAI-1）4G / 5G启动子多态性的研究：病例对照研究
3. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis. [J] . Tsantes AE, Nikolopoulos GK, Bagos PG, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2007 ,第6期

机译：纤溶酶原激活物抑制剂1 4G / 5G多态性与静脉血栓形成之间的关联。荟萃分析。
4. Lack of association of 4G/5G polymorphism in plasminogen activator inhibitor-1 gene with stroke [C] . Masaru Shoji, Shoji Tsutaya, Chiyako Oshikata, Hirosaki International Forum of Medical Science . 2003

机译：血液原激活剂抑制剂-1基因中缺乏4g / 5g多态性的关联卒中
5. Association of the PAI-1 4G/5G polymorphism with blood pressure in the Quebec Family Study: Interactions with adiposity, physical activity, and the ACE I/D polymorphism. [D] . Sarzynski, Mark Andrew. 2008

机译：魁北克家庭研究中PAI-1 4G / 5G多态性与血压的关联：与肥胖，身体活动和ACE I / D多态性的相互作用。
6. Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis [O] . Huifeng Zhang, Pingshuan Dong, Xuming Yang, 2014

机译：纤溶酶原激活物抑制剂1 4G / 5G多态性与冠心病风险相关：一项荟萃分析
7. Residual vein thrombosis and onset of post-thrombotic syndrome: Influence of the ud4G/5G polymorphism of plasminogen activator inhibitor-1 gene [O] . Incalcaterra E, Meli F, Muratori IM, 2014

机译：残留静脉血栓形成和血栓后综合征的发作： ud的影响纤溶酶原激活物抑制剂1基因的4G / 5G多态性

Influence of decreased fibrinolytic activity and plasminogen activator inhibitor-1 4G/5G polymorphism on the risk of venous thrombosis

摘要

著录项

相似文献

相关主题

期刊订阅